Home LiteratureArticle Details
PMID: 25392729 Published · epublish English Journal Article

The Autism Simplex Collection: an international, expertly phenotyped autism sample for genetic and phenotypic analyses.

Molecular autism ·Vol. 5 ·2014-00-00 ·Pages 34

Buxbaum JD, Bolshakova N, Brownfeld JM, Anney RJ, Bender P, Bernier R, Cook EH, Coon H, Cuccaro M, Freitag CM, Hallmayer J, Geschwind D, Klauck SM, Nurnberger JI, Oliveira G, Pinto D, Poustka F, Scherer SW, Shih A, Sutcliffe JS, Szatmari P, Vicente AM, Vieland V, Gallagher L

Abstract

There is an urgent need for expanding and enhancing autism spectrum disorder (ASD) samples, in order to better understand causes of ASD. In a unique public-private partnership, 13 sites with extensive experience in both the assessment and diagnosis of ASD embarked on an ambitious, 2-year program to collect samples for genetic and phenotypic research and begin analyses on these samples. The program was called The Autism Simplex Collection (TASC). TASC sample collection began in 2008 and was completed in 2010, and included nine sites from North America and four sites from Western Europe, as well as a centralized Data Coordinating Center. Over 1,700 trios are part of this collection, with DNA from transformed cells now available through the National Institute of Mental Health (NIMH). Autism Diagnostic Interview-Revised (ADI-R) and Autism Diagnostic Observation Schedule-Generic (ADOS-G) measures are available for all probands, as are standardized IQ measures, Vineland Adaptive Behavioral Scales (VABS), the Social Responsiveness Scale (SRS), Peabody Picture Vocabulary Test (PPVT), and physical measures (height, weight, and head circumference). At almost every site, additional phenotypic measures were collected, including the Broad Autism Phenotype Questionnaire (BAPQ) and Repetitive Behavior Scale-Revised (RBS-R), as well as the non-word repetition scale, Communication Checklist (Children's or Adult), and Aberrant Behavior Checklist (ABC). Moreover, for nearly 1,000 trios, the Autism Genome Project Consortium (AGP) has carried out Illumina 1 M SNP genotyping and called copy number variation (CNV) in the samples, with data being made available through the National Institutes of Health (NIH). Whole exome sequencing (WES) has been carried out in over 500 probands, together with ancestry matched controls, and this data is also available through the NIH. Additional WES is being carried out by the Autism Sequencing Consortium (ASC), where the focus is on sequencing complete trios. ASC sequencing for the first 1,000 samples (all from whole-blood DNA) is complete and data will be released in 2014. Data is being made available through NIH databases (database of Genotypes and Phenotypes (dbGaP) and National Database for Autism Research (NDAR)) with DNA released in Dist 11.0. Primary funding for the collection, genotyping, sequencing and distribution of TASC samples was provided by Autism Speaks and the NIH, including the National Institute of Mental Health (NIMH) and the National Human Genetics Research Institute (NHGRI). TASC represents an important sample set that leverages expert sites. Similar approaches, leveraging expert sites and ongoing studies, represent an important path towards further enhancing available ASD samples.

Authors & Affiliations
24 authors, click to expand affiliations / ORCID
Buxbaum Joseph D
The Seaver Autism Center for Research and Treatment, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York 10029, USA.
Bolshakova Nadia
Autism Genetics Group, Department of Psychiatry, School of Medicine, Trinity College, Dublin 8, Ireland.
Brownfeld Jessica M
The Seaver Autism Center for Research and Treatment, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York 10029, USA.
Anney Richard Jl
Autism Genetics Group, Department of Psychiatry, School of Medicine, Trinity College, Dublin 8, Ireland.
Bender Patrick
National Institute of Mental Health (NIMH), Bethesda, MD 20892-9663, USA.
Bernier Raphael
Department of Psychiatry and Behavioral Sciences, University of Washington, Seattle, WA 98195, USA.
Cook Edwin H
Institute for Juvenile Research, Department of Psychiatry, University of Illinois at Chicago, Chicago, IL 60608, USA.
Coon Hilary
Psychiatry Department, University of Utah Medical School, Salt Lake City, UT 84108, USA.
Cuccaro Michael
The John P Hussman Institute for Human Genomics, University of Miami, Miami, FL 33101, USA.
Freitag Christine M
Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, JW Goethe University Frankfurt, 60528 Frankfurt, Germany.
Hallmayer Joachim
Department of Psychiatry and Behavioral Science, Child and Adolescent Psychiatry, Stanford School of Medicine, Stanford, CA, USA.
Geschwind Daniel
Department of Neurology, University of California at Los Angeles, School of Medicine, Los Angeles, CA 90095, USA.
Klauck Sabine M
German Cancer Research Center (DKFZ), 69120 Heidelberg, Germany.
Nurnberger John I
Department of Psychiatry, Indiana University School of Medicine, Indianapolis, IN 46202, USA.
Oliveira Guiomar
Unidade de Neurodesenvolvimento e Autismo do Serviço do Centro de Desenvolvimento da Criança and Centro de Investigação e Formação Clinica, Pediatric Hospital, Centro Hospitalar e Universitário de Coimbra, 3000-602 Coimbra, Portugal ; University Clinic of Pediatrics and Institute for Biomedical Imaging and Life Science, Faculty of Medicine, University of Coimbra, 3000-602 Coimbra, Portugal.
Pinto Dalila
The Seaver Autism Center for Research and Treatment, Department of Psychiatry, Icahn School of Medicine at Mount Sinai, New York 10029, USA.
Poustka Fritz
Department of Child and Adolescent Psychiatry, Psychosomatics and Psychotherapy, JW Goethe University Frankfurt, 60528 Frankfurt, Germany.
Scherer Stephen W
Department of Molecular Genetics, The Centre for Applied Genomics, Hospital for Sick Children and McLaughlin Centre and University of Toronto, Toronto, ON, Canada.
Shih Andy
Autism Speaks, New York, NY 10016, USA.
Sutcliffe James S
Department of Molecular Physiology and Biophysics, Vanderbilt Kennedy Center, Vanderbilt University, Nashville, TN 37232, USA ; Centers for Human Genetics Research and Molecular Neuroscience, Vanderbilt University, Nashville, TN 37232, USA.
Szatmari Peter
Department of Psychiatry and Behavioural Neurosciences, McMaster University, Hamilton, ON L8N 3Z5, Canada.
Vicente Astrid M
Instituto Nacional de Saúde Dr Ricardo Jorge, 1649-016 Lisbon, Portugal ; Instituto Gulbenkian de Ciência, P-2781-901 Oeiras, Portugal ; BioFIG-Center for Biodiversity, Functional & Integrative Genomics, Campus da FCUL, C2.2.12, Campo Grande, 1749-016 Lisboa, Portugal.
Vieland Veronica
The Research Institute at Nationwide Children's Hospital, The Ohio State University, Columbus, OH, USA.
Gallagher Louise
Autism Genetics Group, Department of Psychiatry, School of Medicine, Trinity College, Dublin 8, Ireland.
References (38)
38 references, click to expand
  1. Etiological heterogeneity in autism spectrum disorders: more than 100 genetic and genomic disorders and still counting.
    Brain Res. 2011 Mar 22;1380:42-77 PMID: 21129364
  2. Autism genome-wide copy number variation reveals ubiquitin and neuronal genes.
    Nature. 2009 May 28;459(7246):569-73 PMID: 19404257
  3. Schizophrenia genetics: the search for a hard lead.
    Curr Opin Psychiatry. 2008 Mar;21(2):157-60 PMID: 18332663
  4. The autism diagnostic observation schedule-generic: a standard measure of social and communication deficits associated with the spectrum of autism.
    J Autism Dev Disord. 2000 Jun;30(3):205-23 PMID: 11055457
  5. Autism as a paradigmatic complex genetic disorder.
    Annu Rev Genomics Hum Genet. 2004;5:379-405 PMID: 15485354
  6. Consensus statement: chromosomal microarray is a first-tier clinical diagnostic test for individuals with developmental disabilities or congenital anomalies.
    Am J Hum Genet. 2010 May 14;86(5):749-64 PMID: 20466091
  7. The broad autism phenotype questionnaire.
    J Autism Dev Disord. 2007 Oct;37(9):1679-90 PMID: 17146701
  8. Genomewide association studies: history, rationale, and prospects for psychiatric disorders.
    Am J Psychiatry. 2009 May;166(5):540-56 PMID: 19339359
  9. De novo mutations revealed by whole-exome sequencing are strongly associated with autism.
    Nature. 2012 Apr 04;485(7397):237-41 PMID: 22495306
  10. Using a parental checklist to identify diagnostic groups in children with communication impairment: a validation of the Children's Communication Checklist--2.
    Int J Lang Commun Disord. 2004 Jul-Sep;39(3):345-64 PMID: 15204445
  11. Economic cost of autism in the UK.
    Autism. 2009 May;13(3):317-36 PMID: 19369391
  12. Narrowing the broader autism phenotype: a study using the Communication Checklist-Adult Version (CC-A).
    Autism. 2010 Nov;14(6):559-74 PMID: 20923891
  13. Mapping autism risk loci using genetic linkage and chromosomal rearrangements.
    Nat Genet. 2007 Mar;39(3):319-28 PMID: 17322880
  14. Structural variation in the human genome and its role in disease.
    Annu Rev Med. 2010;61:437-55 PMID: 20059347
  15. A genome-wide linkage and association scan reveals novel loci for autism.
    Nature. 2009 Oct 8;461(7265):802-8 PMID: 19812673
  16. Integrated model of de novo and inherited genetic variants yields greater power to identify risk genes.
    PLoS Genet. 2013;9(8):e1003671 PMID: 23966865
  17. Using whole-exome sequencing to identify inherited causes of autism.
    Neuron. 2013 Jan 23;77(2):259-73 PMID: 23352163
  18. Randomized, controlled trial of an intervention for toddlers with autism: the Early Start Denver Model.
    Pediatrics. 2010 Jan;125(1):e17-23 PMID: 19948568
  19. The autism sequencing consortium: large-scale, high-throughput sequencing in autism spectrum disorders.
    Neuron. 2012 Dec 20;76(6):1052-6 PMID: 23259942
  20. The Simons Simplex Collection: a resource for identification of autism genetic risk factors.
    Neuron. 2010 Oct 21;68(2):192-5 PMID: 20955926
  21. Autism Diagnostic Interview-Revised: a revised version of a diagnostic interview for caregivers of individuals with possible pervasive developmental disorders.
    J Autism Dev Disord. 1994 Oct;24(5):659-85 PMID: 7814313
  22. Copy-number variants in neurodevelopmental disorders: promises and challenges.
    Trends Genet. 2009 Dec;25(12):536-44 PMID: 19910074
  23. Analysis of rare, exonic variation amongst subjects with autism spectrum disorders and population controls.
    PLoS Genet. 2013 Apr;9(4):e1003443 PMID: 23593035
  24. Changing the landscape of autism research: the autism genetic resource exchange.
    Neuron. 2010 Oct 21;68(2):187-91 PMID: 20955925
  25. Do common variants play a role in risk for autism? Evidence and theoretical musings.
    Brain Res. 2011 Mar 22;1380:78-84 PMID: 21078308
  26. Identification of small exonic CNV from whole-exome sequence data and application to autism spectrum disorder.
    Am J Hum Genet. 2013 Oct 3;93(4):607-19 PMID: 24094742
  27. The lifetime distribution of the incremental societal costs of autism.
    Arch Pediatr Adolesc Med. 2007 Apr;161(4):343-9 PMID: 17404130
  28. De novo gene disruptions in children on the autistic spectrum.
    Neuron. 2012 Apr 26;74(2):285-99 PMID: 22542183
  29. Prevalence of autism spectrum disorders - Autism and Developmental Disabilities Monitoring Network, United States, 2006.
    MMWR Surveill Summ. 2009 Dec 18;58(10):1-20 PMID: 20023608
  30. A genome-wide scan for common alleles affecting risk for autism.
    Hum Mol Genet. 2010 Oct 15;19(20):4072-82 PMID: 20663923
  31. The aberrant behavior checklist: a behavior rating scale for the assessment of treatment effects.
    Am J Ment Defic. 1985 Mar;89(5):485-91 PMID: 3993694
  32. Transmission disequilibrium of small CNVs in simplex autism.
    Am J Hum Genet. 2013 Oct 3;93(4):595-606 PMID: 24035194
  33. Sporadic autism exomes reveal a highly interconnected protein network of de novo mutations.
    Nature. 2012 Apr 04;485(7397):246-50 PMID: 22495309
  34. The Repetitive Behavior Scale-Revised: independent validation in individuals with autism spectrum disorders.
    J Autism Dev Disord. 2007 May;37(5):855-66 PMID: 17048092
  35. Rare complete knockouts in humans: population distribution and significant role in autism spectrum disorders.
    Neuron. 2013 Jan 23;77(2):235-42 PMID: 23352160
  36. Patterns and rates of exonic de novo mutations in autism spectrum disorders.
    Nature. 2012 Apr 04;485(7397):242-5 PMID: 22495311
  37. Combining information from multiple sources in the diagnosis of autism spectrum disorders.
    J Am Acad Child Adolesc Psychiatry. 2006 Sep;45(9):1094-103 PMID: 16926617
  38. Functional impact of global rare copy number variation in autism spectrum disorders.
    Nature. 2010 Jul 15;466(7304):368-72 PMID: 20531469
Article Info
Journal
Molecular autism
Abbr.
Mol Autism
ISSN
2040-2392
Published
2014-00-00
Epub
2014-00-20
Pages
34
Language
English
Region
England
NLM ID
101534222
PMCID
PMC4228819
Grants
NIMH NIH HHS · R01 MH094400 · United States
NIMH NIH HHS · U01 MH100233 · United States
NICHD NIH HHS · U54 HD083091 · United States
Analysis Services
Analysis Services

Contact

No. 2 Wenbo Road, Zhangqiu District, Jinan, Shandong

Qilu Normal University · Genelibs Bioinformatics Lab

750 Shunhua Rd, Jinan

2F, Bldg F, University Science Park

Tel: 0531-88819269

WeChat Official Account

Follow our WeChat subscription account for real-time updates and the latest in medical and biological research.


Business Email

E-mail: [email protected]